Share
Journal Information
Issue
Vol. 42. Issue 1.Pages 1-102 (January - March 2020)
Scientific comments
Original articles
Chronic transfusion therapy effectiveness as primary stroke prophylaxis in sickle cell disease patients
Juliana Moreira Franco, Carla Caroline Lopes Borges, Marília Alves Ansaloni, Renata Dudnick de Lima Mauro, Ylle Carolinne da Cruz Souza, Josefina Aparecida Pellegrini Braga
Hematol Transfus Cell Ther. 2020;42:12-7
Open access
Cytomegalovirus disease in patients with hematopoietic stem cell transplantation, experience over 8 years
Laura Diaz, Joaquin Rosales, Fernando Rosso, Maria Rosales, Mayra Estacio, Eliana Manzi, Francisco Javier Jaramillo
Hematol Transfus Cell Ther. 2020;42:18-24
Open access
Predictors of mortality among patients with acute leukemias admitted to an intensive care unit specialized in patients with hematological disease at a Brazilian hospital
Lorena Costa Corrêa, Dahra Teles, Odin Barbosa da Silva, Gustavo Henriques Trindade-Filho, Paula Loureiro, Maria do Socorro Mendonça Cavalcati
Hematol Transfus Cell Ther. 2020;42:33-9
Open access
Haploidentical transplantation outcomes are comparable with those obtained with identical human leukocyte antigen allogeneic transplantation in Chilean patients with benign and malignant hemopathies
Mauricio Sarmiento, Pablo Ramirez, Veronica Jara, Pablo Bertin, Mauricio Galleguillos, Isabel Rodriguez, Carla Lorca, Isabel Pizarro, ... Mauricio Ocqueteau
Hematol Transfus Cell Ther. 2020;42:40-5
Open access
A subgroup analysis of JUMP, a phase IIIb, expanded-access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis in a Brazilian cohort
Renato Tavares, Carmino Antonio De Souza, Carole Paley, Catherine Bouard, Ranjan Tiwari, Ricardo Pasquini
Hematol Transfus Cell Ther. 2020;42:46-53
Open access
PEG-asparaginase and native Escherichia coli L-asparaginase in acute lymphoblastic leukemia in children and adolescents: a systematic review
Camile Valle Medawar, Gabriela Bittencourt Gonzalez Mosegui, Cid Manso de Mello Vianna, Talita Martins Alves da Costa
Hematol Transfus Cell Ther. 2020;42:54-61
Open access
Review article
Special article
A functional interaction between the CCR5 and CD34 molecules expressed in hematopoietic cells can support (or even promote) the development of cancer
Bruna Kulmann-Leal, Joel Henrique Ellwanger, José Artur Bogo Chies
Hematol Transfus Cell Ther. 2020;42:70-6
Open access
Case reports
Spontaneous splenic rupture associated with multiple myeloma: a serious and unusual case
Denise Fabri Rezende Engracia Mello, Mauro José Brandão da Costa, Eduardo Miguel Febronio, Glaucia Aparecida Magnani Landell, Rodolfo Mendes Queiroz
Hematol Transfus Cell Ther. 2020;42:83-6
Open access
Letters to the editor
Interim interleukin 6 levels correlate with progression-free survival in patients with classic Hodgkin's disease: a pilot study
Pamela Villanova, Vitor Augusto Queiroz Mauad, Davimar Miranda Maciel Borducchi, Auro del Giglio
Hematol Transfus Cell Ther. 2020;42:90-2
Open access
Non-indolent mantle cell lymphoma at a single public hospital in Brazil: real world first-line treatment cohort study data
Sergio Augusto Buzian Brasil, Carolina Colaço, Tomas Barrese, Roberto P. Paes, Cristina Bortolheiro, Rodolfo Delfini Cançado
Hematol Transfus Cell Ther. 2020;42:93-7
Open access
Publish in
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.
www.publicationethics.org.